Rangaraju S, Solis G, Thompson R, Gomez Amaro R, Kurian L, Encalada S, et al. Suppression of transcriptional drift extends C. elegans lifespan by postponing the onset of mortality. elife. 2015;4:e08833 pubmed publisher

Kamińska K, Rogóż Z. The effect of combined treatment with risperidone and antidepressants on the MK-801-induced deficits in the social interaction test in rats. Pharmacol Rep. 2015;67:1183-7 pubmed publisher

Rossmann J, Gurke R, Renner L, Oertel R, Kirch W. Evaluation of the matrix effect of different sample matrices for 33 pharmaceuticals by post-column infusion. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;1000:84-94 pubmed publisher

Otvos R, Iyer J, van Elk R, Ulens C, Niessen W, Somsen G, et al. Development of Plate Reader and On-Line Microfluidic Screening to Identify Ligands of the 5-Hydroxytryptamine Binding Protein in Venoms. Toxins (Basel). 2015;7:2336-53 pubmed publisher

de Souza I, Domingues D, Queiroz M. Hybrid silica monolith for microextraction by packed sorbent to determine drugs from plasma samples by liquid chromatography-tandem mass spectrometry. Talanta. 2015;140:166-175 pubmed publisher

Evans S, Davies P, Lubben A, Kasprzyk Hordern B. Determination of chiral pharmaceuticals and illicit drugs in wastewater and sludge using microwave assisted extraction, solid-phase extraction and chiral liquid chromatography coupled with tandem mass spectrometry. Anal Chim Acta. 2015;882:112-26 pubmed publisher

Domingues D, Souza I, Queiroz M. Analysis of drugs in plasma samples from schizophrenic patients by column-switching liquid chromatography-tandem mass spectrometry with organic-inorganic hybrid cyanopropyl monolithic column. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;993-994:26-35 pubmed publisher

Olianas M, Dedoni S, Onali P. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts. Biochem Pharmacol. 2015;95:311-23 pubmed publisher

Gurke R, Rossmann J, Schubert S, Sandmann T, Rößler M, Oertel R, et al. Development of a SPE-HPLC-MS/MS method for the determination of most prescribed pharmaceuticals and related metabolites in urban sewage samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;990:23-30 pubmed publisher

Kemp D. Managing the side effects associated with commonly used treatments for bipolar depression. J Affect Disord. 2014;169 Suppl 1:S34-44 pubmed publisher

de Bejczy A, Söderpalm B. The effects of mirtazapine versus placebo on alcohol consumption in male high consumers of alcohol: a randomized, controlled trial. J Clin Psychopharmacol. 2015;35:43-50 pubmed publisher

Okubo M, Murayama N, Miura J, Chiba Y, Yamazaki H. Effects of cytochrome P450 2D6 and 3A5 genotypes and possible coadministered medicines on the metabolic clearance of antidepressant mirtazapine in Japanese patients. Biochem Pharmacol. 2015;93:104-9 pubmed publisher

Chang H, Won E, Lee H, Ham B, Kim Y, Lee M. The association of proopiomelanocortin polymorphisms with the risk of major depressive disorder and the response to antidepressants via interactions with stressful life events. J Neural Transm (Vienna). 2015;122:59-68 pubmed publisher

Kamińska K, Gołembiowska K, Rogóż Z. The effect of risperidone on the mirtazapine-induced changes in extracellular monoamines in the rat frontal cortex. Pharmacol Rep. 2014;66:984-90 pubmed publisher

Mut L, Grobosch T, Binscheck Domaß T, Frenzel W. Toxicological screening of human plasma by on-line SPE-HPLC-DAD: identification and quantification of basic drugs and metabolites. Biomed Chromatogr. 2015;29:935-52 pubmed publisher

Sempio C, Morini L, Vignali C, Groppi A. Simple and sensitive screening and quantitative determination of 88 psychoactive drugs and their metabolites in blood through LC-MS/MS: application on postmortem samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;970:1-7 pubmed publisher

Muguruza C, Miranda Azpiazu P, Díez Alarcia R, Morentin B, González Maeso J, Callado L, et al. Evaluation of 5-HT2A and mGlu2/3 receptors in postmortem prefrontal cortex of subjects with major depressive disorder: effect of antidepressant treatment. Neuropharmacology. 2014;86:311-8 pubmed publisher

Paulzen M, Gründer G, Tauber S, Veselinovic T, Hiemke C, Groppe S. Distribution pattern of mirtazapine and normirtazapine in blood and CSF. Psychopharmacology (Berl). 2015;232:807-13 pubmed publisher

Tsai J, Kuo C, Yang P, Cheng K, Wang P, Chen C, et al. Effects of antidepressants on IP-10 production in LPS-activated THP-1 human monocytes. Int J Mol Sci. 2014;15:13223-35 pubmed publisher

Chang H, Lee H, Cha J, Won E, Ham B, Kim B, et al. Interaction of 5-HTT and HTR1A gene polymorphisms in treatment responses to mirtazapine in patients with major depressive disorder. J Clin Psychopharmacol. 2014;34:446-54 pubmed publisher

Milne B, Sutak M, Cahill C, Jhamandas K. Low doses of alpha 2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance. Br J Pharmacol. 2008;155:1264-78 pubmed publisher

Anttila S, Leinonen E. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001;7:249-64 pubmed

Raji M, Brady S. Mirtazapine for treatment of depression and comorbidities in Alzheimer disease. Ann Pharmacother. 2001;35:1024-7 pubmed